A spayed female mixed-breed cat of unknown age (presumably >9 years old), weighing 2.9 kg, was presented with a 4 day history of lethargy, anorexia and vomiting (day 1). The cat had a history of bilateral ureteral calculi removed by surgical operation 1 month prior to the current presentation and hypertension that had been treated with oral administration of prazosin (0.17 mg/kg q12h Minipress [Pfizer]) for 2 months.
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Case description
A spayed female mixed-breed cat of unknown age (presumably >9 years old), weighing 2.9 kg, was presented with a 4 day history of lethargy, anorexia and vomiting (day 1). The cat had a history of bilateral ureteral calculi removed by surgical operation 1 month prior to the current presentation and hypertension that had been treated with oral administration of prazosin (0.17 mg/kg q12h Minipress [Pfizer]) for 2 months.
Bacterial cystitis was detected in the cat 14 days prior to the current presentation. Although bacterial identification was not performed, the antimicrobial susceptibility test revealed multidrug resistance to bacteria in the urine sample and fosfomycin was shown to be a susceptible antibiotic. Based on the result of the antimicrobial susceptibility test, oral administration of calcium fosfomycin (20 mg/kg q12h Fosmicin [Meiji Seika Pharma]) was initiated 7 days prior to the current presentation. The cat began to vomit 4 days after initiation of treatment with fosfomycin.
A serum biochemical analysis on day 1 detected a dramatic increase in the levels of blood urea nitrogen (BUN; >140 mg/dl; reference interval [RI] 17.6-32.8 mg/dl) and creatinine (15.3 mg/dl; RI 0.8-1.8 mg/dl), and hypercalcaemia (13.1 mg/dl; RI 8.8-11.9 mg/dl), hyperphosphataemia (13.3 mg/dl; RI 2.6-6.0 mg/dl) and hyperkalaemia (6.1 mmol/l; RI 3.4-4.6 mmol/l). In a serum biochemical analysis that was performed 3 weeks prior to day 1 of admission, the levels of BUN, creatinine and potassium were within normal reference intervals; those of calcium and phosphate were not measured in the analysis.
An abdominal ultrasound on day 1 did not illustrate any specific findings, including calculi in the right and left kidneys and both ureters. Based on the clinical course and a serum biochemical analysis, the cat was diagnosed with acute renal failure (ARF) induced by oral administration of fosfomycin.
The After euthanasia, the right and left kidneys of the cat were subjected to pathological analysis. No macroscopic findings were detected in the kidneys. The kidneys were fixed in 10% neutral-buffered formalin, processed according to standard protocols and embedded in paraffin. Paraffin sections (5 μm) were stained with haematoxylin and eosin. Renal tubular necrosis was diffusely observed in the cortex (Figure 1a) . Eosinophilia of renal tubular cells with a small amount of pyknotic nuclear debris was observed especially at the pars recta (Figures  1b,c) . Flattened tubular cells with variable sized nuclei and basophilic cytoplasm were occasionally observed with evidence of karyomegaly (Figures 1b,c) . Granular and hyaline casts were frequently seen in the cortex and medulla. Interstitial lymphocyte infiltration was sporadically observed, but renal tubular lipidosis as seen in healthy cats was obscure (Figures 1a-c) . 
Discussion
A previous study demonstrated a nephrotoxic effect of fosfomycin on young cats. 1 Oral administration of calcium fosfomycin (20 mg/kg q12h) in healthy young cats for 3 days increased the serum levels of creatinine significantly and those of BUN less significantly; however, the young cats did not show any clinical signs associated with uraemia, such as anorexia and vomiting. 1 Histopathological analysis revealed tubular necrosis, disappearance of tubular cells and rearrangement of eosinophilic non-structural material in the kidneys of the young cats. 1 In healthy adult cats, oral or intravenous administration of fosfomycin did not increase the levels of BUN and creatinine significantly. However, histopathological changes were observed in the kidneys of the adult cats, 1 suggesting a possible nephrotoxic effect of fosfomycin on adult cats.
The present case report provides, for the first time, clinical and histopathological evidence for fosfomycininduced ARF in an adult cat. The cat began to vomit 4 days after initiation of treatment with fosfomycin. It is, therefore, conceivable that the renal function was damaged shortly after oral administration of fosfomycin.
The histopathological changes observed in this case were consistent with renal tubular necrosis in cats. [2] [3] [4] Renal tubular necrosis was typically identified as cytoplasmic hypereosinophilia, but the near lack of nuclear debris implied that nuclear karyolysis rather than pyknosis was prominent. The findings suggested a few days or a week-long course of renal damage. 4 This interpretation was in accordance with the evidence of tubular regeneration; ie, flattened basophilic tubular cells that were concomitantly observed in acute tubular necrosis of cats. 2, 5 When ARF developed, the cat was being orally administered with both fosfomycin and prazosin. Thus, we cannot rule out the possibility that prazosin may have also affected the renal function in the cat. As prazosin had been administered to the cat for approximately 2 months prior to the use of fosfomycin, it is very unlikely that a single administration of prazosin induced ARF based on the clinical course and histopathological findings observed. Alternatively, it is possible that the concurrent administration of fosfomycin and prazosin might have induced ARF in the cat, although this effect has never been reported previously. Further studies will be required to investigate the possible nephrotoxic effect of concurrent use of fosfomycin and prazosin in cats.
Conclusions
Not all adult cats develop ARF after administration of fosfomycin. As the mechanisms underlying the nephrotoxity of fosfomycin in cats remain unclear, it is impossible to distinguish between fosfomycin-sensitive and non-sensitive cats. Therefore, it is highly advisable that fosfomycin should not be used in either young or adult cats.
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